15 results on '"Kim, H.R."'
Search Results
2. Design, synthesis and evaluation of new pyrimidine derivatives for novel ALK/ROS1 inhibitors
3. 2224 Comparison of adjuvant chemoradiation to peri-operative chemotherapy for the treatment of resected gastric and gastroesophageal junction adenocarincoma
4. 3048 The effect of combined treatment with COX-2 inhibitor and EGFR inhibitor in lung cancer cell lines
5. 393 Small modification of ceritinib enhances the activity against ALK
6. 622: Immunohistochemical evaluation of the mammalian target of rapamycin pathway in stage I non-small cell lung carcinoma
7. 768: MDR1 confers the acquired resistance to 17-DMAG in lung cancer with ALK rearrangement
8. 626: Autophagosome-mediated EGFR down-regulation induced by CK2 inhibitor enhances the efficacy of EGFR-TKI on EGFR-mutant lung cancer cells with T790M
9. 483: Assessment of fibroblast growth factor receptor 2 amplification in gastric cancer using quantitative real-time polymerase chain reaction, fluorescent in situ hybridization and immunohistochemistry
10. 621: Prognostic significance of neuroendocrine components in gastric carcinomas
11. 79 - Design, synthesis and evaluation of new pyrimidine derivatives for novel ALK/ROS1 inhibitors
12. 30 - Minor modifications to ceritinib enhance the activity against G1202R mutation, in vivo activity, and BBB penetration
13. 132 Epithelial to Mesenchymal Transition Leads to Crizotinib-resistance in H2228 Lung Cancer Cells with EML4-ALK Translocation
14. 942 KRC-108 as a Potent C-Met/Ron/Flt3 Kinase Inhibitor with Anti-tumor Effects in Vitro and in Vivo
15. 969 Antitumor Activity of NPS-1034, a Synthetic MET and AXL Inhibitor, in Lung Cancer Cells With Resistance to EGFR Tyrosine Kinase Inhibitors by MET or AXL Activation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.